Treg cells in pancreatic lymph nodes: The possible role in diabetogenesis and β cell regeneration in a T1D model

Cellular and Molecular Immunology

Volumn 9, Issue 6, 2012, Pages 455-463

  Nti, Benjamin K ^a   Markman, Janet L ^b   Bertera, Suzanne ^c   Styche, Alexis J ^c   Lakomy, Robert J ^c   Subbotin, Vladimir M ^d   Trucco, Massimo ^c   Zorina, Tatiana D ^e  

^a INDIANA UNIVERSITY   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c CHILDREN S HOSPITAL OF PITTSBURGH   (United States)

^d Thomas Jefferson University ^*  (United States)

^e THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

T regulatory cell trafficking; Type 1 diabetes; cell regeneration

Indexed keywords

CHEMOKINE; STROMAL CELL DERIVED FACTOR 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; AUTOIMMUNITY; B LYMPHOCYTE; CELL MIGRATION; CELL POPULATION; CELL REGENERATION; DIABETOGENESIS; FEMALE; IMMUNOMODULATION; INSULIN DEPENDENT DIABETES MELLITUS; LYMPH NODE; MOUSE; NONHUMAN; PANCREAS; REGULATORY T LYMPHOCYTE; SPLEEN CELL;

EID: 84868591487     PISSN: 16727681     EISSN: None     Source Type: Journal    
DOI: 10.1038/cmi.2012.36     Document Type: Article

References (46)

1. Kleiner IS, Meltzer SJ. Retention in the circulation of dextrose in normal and depancreatized animals, and the effect of an intravenous injection of an emulsion of pancreas upon this retention. Proc Natl Acad Sci USA 1915; 1: 338-341.
2. Banting FG, Best CH, Collip JB, Campbell WR, Fletcher AA. Pancreatic extracts in the treatment of diabetes mellitus: Preliminary report. 1922. CMAJ 1991; 145: 1281-1286.
3. Lacy PE, Kostianovsky M. Method for the isolation of intact islets of Langerhans from the rat pancreas. Diabetes 1967; 16: 35-39.
4. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL et al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 2000; 343: 230-238. (Pubitemid 30490390)
5. Selam JL. External and implantable insulin pumps: Current place in the treatment of diabetes. Exp Clin Endocrinol Diabetes 2001; 109(SUPPL2): S333-S340. (Pubitemid 32577591)
6. Tanna S, Joan Taylor M, Sahota TS, Sawicka K. Glucose-Responsive UV polymerised dextran-Concanavalin A acrylic derivatised mixtures for closed-loop insulin delivery. Biomaterials 2006; 27: 1586-1597. (Pubitemid 41739584)
7. Gepts W. 1965. Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 1965; 14: 619-633.
8. Ogawa N, List JF, Habener JF, Maki T. Cure of overt diabetes in NOD mice by transient treatment with anti-lymphocyte serum and exendin-4. Diabetes 2004; 53: 1700-1705. (Pubitemid 38857027)
9. Suri A, Calderon B, Esparza TJ, Frederick K, Bittner B, Unanue ER. Immunological reversal of autoimmune diabetes without hematopoietic replacement of beta cells. Science 2006; 311: 1778-1780.
10. Sherry NA, Chen W, Kushner JA, Glandt M, Tang Q, Tsai S et al. Exendin-4 improves reversal of diabetes in NOD mice treated with anti-CD3 monoclonal antibody by enhancing recovery of beta-Cells. Endocrinology 2007; 148: 5136-5144. (Pubitemid 350012634)
11. Weir GC, Bonner-Weir S. Dreams for type 1 diabetes: Shutting off autoimmunity and stimulating beta-Cell regeneration. Endocrinology 2010; 151: 2971-2973.
12. Alipio Z, Liao W, Roemer EJ, Waner M, Fink LM, Ward DC et al. Reversal of hyperglycemia in diabetic mouse models using induced-Pluripotent stem (iPS)-derived pancreatic beta-like cells. Proc Natl Acad Sci USA 2010; 107: 13426-13431.
13. Tsai S, Shameli A, Yamanouchi J, Clemente-Casares X, Wang J, Serra P et al. Reversal of autoimmunity by boosting memory-like autoregulatory T cells. Immunity 2010; 32: 568-580.
14. Chatenoud L, Thervet E, Primo L, Bach JF. Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice. Proc Natl Acad Sci USA 1994; 91: 123-127. (Pubitemid 24018655)
15. Serreze DV, Gaedeke JW, Leiter EH. Hematopoietic stem-Cell defects underlying abnormal macrophage development and maturation in NOD/Lt mice: Defective regulation of cytokine receptors and protein kinase C. Proc Natl Acad Sci USA 1993; 90: 9625-9629. (Pubitemid 23315838)
16. Zorina TD, Kaufman CL, Ildstad ST. Mixed allogeneic chimerism for the prevention of autoimmune diabetes, and the reversal of insulitis in the non-obese diabetic (NOD) mouse. J Immunol 1993; 150(8 part II): A80.
17. Li H, Kaufman CL, Boggs SS, Johnson PC, Patrene KD, Ildstad ST. Mixed allogeneic chimerism induced by a sublethal approach prevents autoimmune diabetes and reverses insulitis in nonobese diabetic (NOD) mice. J Immunol 1996; 156: 380-388.
18. Zorina TD, Subbotin VM, Bertera S, Alexander AM, Haluszczak C, Gambrell B et al. Recovery of the endogenous beta cell function in the NOD model of autoimmune diabetes. Stem Cells 2003; 21: 377-388. (Pubitemid 36793482)
19. Tian B, Hao J, Zhang Y, Tian L, Yi H, O'Brien TD et al. Upregulating CD41CD251FOXP31 regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy. Transplantation 2009; 87: 198-206.
20. Kim JM, Rasmussen JP, Rudensky AY. Regulatory T cells prevent catastrophic autoimmunity throughout the lifespan of mice. Nat. Immunol 2007; 8: 191-197. (Pubitemid 46152650)
21. BluestOne JA, Tang Q, Sedwick CE. T regulatory cells in autoimmune diabetes: Past challenges, future prospects. J Clin Immunol 2008; 28: 677-684.
22. Homann D, von Herrath M. Regulatory T cells and type 1 diabetes. Clin Immunol 2004; 112: 202-209. (Pubitemid 39078692)
23. Jaeckel E, von Boehmer H, Manns MP. Antigen-specific FoxP3-transduced T-Cells can control established type 1 diabetes. Diabetes 2005; 54: 306-310.
24. D'Alise AM, Auyeung V, Feuerer M, Nishio J, Fontenot J, Benoist C et al. The defect in T-Cell regulation in NOD mice is an effect on the T-Cell effectors. Proc Natl Acad Sci USA 2008; 105: 19857-19862.
25. Tritt M, Sgouroudis E, d'Hennezel E, Albanese A, Piccirillo CA. Functional waning of naturally occurring CD41 regulatory T-Cells contributes to the onset of autoimmune diabetes. Diabetes 2008; 57: 113-123.
26. Aboumrad E, Madec AM, Thivolet C. The CXCR4/CXCL12 (SDF-1) signalling pathway protects non-obese diabetic mouse from autoimmune diabetes. Clin Exp Immunol 2007; 148: 432-439. (Pubitemid 46701033)
27. Aspord C, Czerkinsky C, Durand A, Stefanutti A, Thivolet C. Alpha4 integrins and Lselectin differently orchestrate T-Cell activity during diabetes prevention following oral administration of CTB-insulin. J. Autoimmun 2002; 19: 223-232. (Pubitemid 36262937)
28. Leng Q, Nie Y, Zou Y, Chen J. Elevated CXCL12 expression in the bOne marrow of NOD mice is associated with altered T cell and stem cell trafficking and diabetes development. BMC Immunol 2008; 9: 51.
29. Szalai C, Csaszar A, Czinner A, Szabo T, Panczel P, Madacsy L et al. Chemokine receptor CCR2 and CCR5 polymorphisms in children with insulin-dependent diabetes mellitus. Pediatr Res 199; 46: 82-84.
30. Tonkin DR, Haskins K. Regulatory T cells enter the pancreas during suppression of type 1 diabetes and inhibit effector T cells and macrophages in a TGF-Beta-dependent manner. Eur J Immunol 2008; 39: 1313-1322.
31. Ildstad ST, Wren SM, BluestOne JA, Barbieri SA, Sachs DH. Characterization of mixed allogeneic chimeras. Immunocompetence, in vitro reactivity, and genetic specificity of tolerance. J Exp Med 1985; 162: 231-244. (Pubitemid 15029899)
32. Zorina TD, Subbotin VM, Bertera S, Alexander AM, Haluszczak C, Styche AJ et al. Distinct characteristics and features of allogeneic chimerism in theNODmouse model of autoimmune diabetes. Cell Transplant 2002; 11: 113-123. (Pubitemid 34594761)
33. Soderstrom I, Bergman ML, Colucci F, Lejon K, Bergqvist I, Holmberg D. Establishment and characterization of RAG-2 deficient non-obese diabetic mice. Scand J Immunol 1996; 43: 525-530. (Pubitemid 26165007)
34. Fontenot JD, Gavin MA, Rudensky AY. Foxp3 programs the development and function of CD41CD251 regulatory cells. Nat Immunol 2003; 4: 330-336. (Pubitemid 36432314)
35. Kukreja A, Cost G, Marker J, Zhang C, Sun Z, Lin-Su K et al. Multiple immunoregulatory defects in type-1 diabetes. J Clin Invest 2002; 109: 131-140. (Pubitemid 34052549)
36. Putnam AL, Vendrame F, Dotta F, Gottlieb PA. CD41CD25high regulatory T cells in human autoimmune diabetes. J Autoimmun 2005; 24: 55-62. (Pubitemid 40269495)
37. Brusko T, Wasserfall C, McGrail K, Schatz R, Viener HL, Schatz D et al. No alterations in the frequency of FOXP31 regulatory T-Cells in type 1 diabetes. Diabetes 2007; 56: 604-612. (Pubitemid 46348451)
38. Hoglund P, Mintern J, Waltzinger C, Heath W, Benoist C, Mathis D. Initiation of autoimmune diabetes by developmentally regulated presentation of islet cell antigens in the pancreatic lymph nodes. J Exp Med 1999; 189: 331-339. (Pubitemid 29063254)
39. Gregori S, Giarratana N, Smiroldo S, Adorini L. Dynamics of pathogenic and suppressor T cells in autoimmune diabetes development. J Immunol 2003; 171: 4040-4047. (Pubitemid 37238678)
40. Dubois-Laforgue D, Hendel H, Caillat-Zucman S, Zagury JF, Winkler C, Boitard C et al. A common stromal cell-derived factor-1 chemokine gene variant is associated with the early onset of type 1 diabetes. Diabetes 2001; 50: 1211-1213. (Pubitemid 32374556)
41. Ide A, Kawasaki E, Abiru N, Sun F, Fukushima T, Takahashi R et al. Stromal-Cell derived factor-1 chemokine gene variant is associated with type 1 diabetes age at onset in Japanese population. Hum Immunol 2003; 64: 973-978. (Pubitemid 37210849)
42. Ara T, Tokoyoda K, Sugiyama T, Egawa T, Kawabata K, Nagasawa T. Long-term hematopoietic stem cells require stromal cell-derived factor-1 for colonizing bOne marrow during ontogeny. Immunity 2003; 19: 257-267. (Pubitemid 37011340)
43. Seung E, Iwakoshi N, Woda BA, Markees TG, Mordes JP, Rossini AA et al. Allogeneic hematopoietic chimerism in mice treated with sublethal myeloablation and anti-CD154 antibody: Absence of graft-versus-host disease, induction of skin allograft tolerance, and prevention of recurrent autoimmunity in islet-allografted NOD/Lt mice. Blood 2000; 95: 2175-2182. (Pubitemid 30151663)
44. Belghith M, BluestOne JA, Barriot S, Megret J, Bach JF, Chatenoud L. TGF-Betadependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes. Nat Med 2003; 9: 1202-1208. (Pubitemid 37173706)
45. Tarbell KV, Yamazaki S, Olson K, Toy P, Steinman RM. CD251 CD41 T cells, expanded with dendritic cells presenting a single autoantigenic peptide, suppress autoimmune diabetes. J Exp Med 2004; 199: 1467-1477. (Pubitemid 38780402)
46. Tang Q, Henriksen KJ, Bi M, Finger EB, Szot G, Ye J et al. In vitro-expanded antigenspecific regulatory T cells suppress autoimmune diabetes. J Exp Med 2004; 199: 1455-1465. (Pubitemid 38780401)